InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,079.55
(
0.18%
)
US TECH 100
17,064.40
(
0.36%
)
Dow Jones
38,519.00
(
0.04%
)
Brent Oil
86.97
(
-0.69%
)
Bitcoin
64,829.31
(
-2.38%
)
Post# of 14668
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Jimmy Swaggert

Send PM Follow Ignore
Followers 26
Posts 1702
Boards Moderated 0
Alias Born 05/02/2013

Jimmy Swaggert

Re: stolles8 post# 13160

Monday, 05/20/2019 1:25:15 PM

Monday, May 20, 2019 1:25:15 PM

Post# of 14668
"Anywhere from 300 to 3,000 participants are required to conduct Phase III clinical trials. Phase III trials have the largest base of patients, all living with the targeted condition that the drug id intended to treat.

As the most time-consuming and demanding trial in which to be involved, Phase III research uses patients with similar demographic traits and tests them for a duration of two to five years."

Never buy, sell or hold any of the stocks in my posts. I'm not an advisor of any kind. I'm an uneducated penny stock buffoon here for your amusement.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up